In vivo electrophysiological study of vitamin D3 protective effects on PTZ-induced seizures in rats
Abstract
Background and purpose: The purpose of the current study was to investigate the protective effects of acute and chronic administration of different doses of vitamin D3 on pentylenetetrazol (PTZ)-induced epileptiform activities in rats.
Experimental approach: Sixty Wistar rats in chronic and acute groups were used in this study. In the chronic groups, animals received vitamin D3 at 50, 100, and 150 μg/kg; vitamin D3 (50 μg/kg, i.p.) + diazepam (0.1 mg/kg, i.p.), and almond oil (i.p.) daily for two weeks whereas, in the acute groups the animal received a single dose of chemicals just 30 min before PTZ administration. The electrophysiological recording was performed by implanting a unilateral bipolar electrode in the pyramidal cell layer of the CA1 region of the hippocampus. Epileptic activities were induced by intraperitoneal injection of PTZ (80 mg/kg, i.p.). The spike count and amplitude were analyzed using the eTrace software.
Finding/Results: Chronic administration of all doses of vitamin D3 and its combination with diazepam significantly reduced both spike counts and amplitudes following PTZ administration. While the acute doses were ineffective.
Conclusion and implication: The results of the study indicated that chronic but not acute administration of vitamin D3 has a protective effect on PTZ-induced epileptiform activity in rats.
Keywords
Full Text:
PDFReferences
Momeni SN, Masoud SA, Banafshe HR. Inhibitory effects of chronic administration of vitamin D3 on pentylenetetrazole-induced seizures in mice. Epilepsy Res. 2019;149:76-82.DOI: 10.1016/j.eplepsyres.2018.11.011.
Holló A, Clemens Z, Kamondi A, Lakatos P, Szűcs A. Correction of vitamin D deficiency improves seizure control in epilepsy: a pilot study. Epilepsy Behav. 2012;24(1):131-133.DOI: 10.1016/j.yebeh.2012.03.011.
Ghaderi A, Banafshe HR, Motmaen M, Rasouli-Azad M, Bahmani F, Asemi Z. Clinical trial of the effects of vitamin D supplementation on psychological symptoms and metabolic profiles in maintenance methadone treatment patients. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79(Pt B):84-89.DOI: 10.1016/j.pnpbp.2017.06.016.
Patrick K, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med. 2011;365(10):919-926.DOI: 10.1056/NEJMra1004418.
Palizvan MR, Ghaznavi-Rad E. Naloxane enhanced inhibitory effect of verapamil on seizure induced by pentylenetetrazol in male rats. Res Pharm Sci. 2014;9(4):295-299.PMID: 25657801.
Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, et al. Animal models of epilepsy: use and limitations. Neuropsychiatr Dis Treat. 2014;10:1693-1705.DOI: 10.2147/NDT.S50371.
Janjoppi L, Katayama MH, Scorza FA, Folgueira MAAK, Brentani M, Pansani AP, et al. Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine. Brain Res Bull. 2008;76(5):480-484.DOI: 10.1016/j.brainresbull.2008.01.002.
Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P. Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci Lett. 2006;394(1):69-73.DOI: 10.1016/j.neulet.2005.10.007.
Wilson HR, Cowan JD. Excitatory and inhibitory interactions in localized populations of model neurons. Biophys J. 1972;12(1):1-24.DOI: 10.1016/S0006-3495(72)86068-5.
Siegel A, Malkowitz L, Moskovits MJ, Christakos S. Administration of 1, 25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res. 1984;298(1):125-129.DOI: 10.1016/0006-8993(84)91153-3.
Bhattarai P, Bhattarai JP, Kim MS, Han SK. Non-genomic action of vitamin D3 on N-methyl-D-aspartate and kainate receptor-mediated actions in juvenile gonadotrophin-releasing hormone neurons. Reprod Fertil Dev. 2017;29(6):1231-1238.DOI: 10.1071/RD15357.
Rashan S, Panahi Y, Khalilzadeh E. Stimulatory and inhibitory effects of morphine on pentylenetetrazol-induced epileptic activity in rat. Int J Neurosci. 2021;131(9):885-893. DOI: 10.1080/00207454.2020.1759591.
Paxinos G, Watson CR, Emson PC. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods. 1980;3(2):129-149. DOI: 10.1016/0165-0270(80)90021-7.
Kalueff AV, Minasyan A, Tuohimaa P. Anticonvulsant effects of 1, 25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull. 2005;67(1-2):156-160.DOI: 10.1016/j.brainresbull.2005.06.022.
Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319-329.DOI: 10.1016/j.chembiol.2013.12.016.
Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13(3):100-105.DOI: 10.1016/S1043-2760(01)00547-1.
Harms LR, Burne TH, Eyles DW, McGrath JJ. Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab. 2011;25(4):657-669.DOI: 10.1016/j.beem.2011.05.009.
Neveu I, Naveilhan P, Menaa C, Wion D, Brachet P, Garabedian M. Synthesis of 1, 25‐dihydroxyvitamin D3 by rat brain macrophages in vitro. J Neurosci Res. 1994;38(2):214-220.DOI: 10.1002/jnr.490380212.
Pendo K, DeGiorgio CM, Michael C. Vitamin D for the treatment of epilepsy: basic mechanisms, animal models and clinical trials. Front Neurol. 2016;7:218,1-6.DOI: 10.3389/fneur.2016.00218.
Leila Z, Paola BG, Gonçalves R,, Pierozan P, Winkelmann-Duarte EC, Woehl VM, et al. 1α, 25-dihydroxyvitamin D(3) mechanism of action: modulation of L-type calcium channels leading to calcium uptake and intermediate filament phosphorylation in cerebral cortex of young rats. Biochim Biophys Acta. 2012;1823(10):1708-1719.DOI: 10.1016/j.bbamcr.2012.06.023.
Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci. 2001;21(1):98-108.DOI: 10.1523/JNEUROSCI.21-01-00098.2001.
Christiansen C, Rødbro P, Sjö O. “Anticonvulsant action” of vitamin D in epileptic patients?A controlled pilot study. Br Med J. 1974;2(5913): 258-259.DOI: 10.1136/bmj.2.5913.258.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.